Table 3. Overall and progression-free survival by indicated year following baseline.
Inflammatory marker | Overall survival, percentage (95% CI) | Progression-free survival, percentage (95% CI) | |||||
---|---|---|---|---|---|---|---|
1-Year | 3-Year | 5-Year | 1-Year | 3-Year | 5-Year | ||
NLR¶ | |||||||
Q1 (≤2.1) | 0.80 (0.72–0.85) | 0.50 (0.41–0.59) | 0.39 (0.28–0.49) | 0.45 (0.36–0.54) | 0.17 (0.11–0.26) | 0.13 (0.06–0.22) | |
Q2 (>2.1-3.0) | 0.82 (0.74–0.87) | 0.45 (0.36–0.53) | 0.38 (0.29–0.47) | 0.53 (0.44–0.62) | 0.24 (0.16–0.32) | 0.19 (0.12–0.28) | |
Q3 (>3.0-4.1) | 0.74 (0.66–0.80) | 0.36 (0.28–0.45) | 0.24 (0.16–0.33) | 0.41 (0.32–0.50) | 0.10 (0.05–0.17) | 0.09 (0.04–0.15) | |
Q4 (>4.1) | 0.69 (0.61–0.76) | 0.24 (0.16–0.31) | 0.20 (0.13–0.29) | 0.35 (0.27–0.44) | 0.14 (0.08–0.22) | 0.12 (0.06–0.20) |
¶, back-transformed from logarithmic values. CI, confidence interval; Q, quartile.